Eisai
4523.T
#2392
Rank
โ‚น761.79 B
Marketcap
โ‚น2,699
Share price
0.70%
Change (1 day)
19.65%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: โ‚น50.63 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น50.63 Billion, an increase over its 2022 earnings that were of -โ‚น2.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023โ‚น50.63 B-2404.04%
2022-โ‚น2.2 Billion-103.6%
2021โ‚น61.11 B-39.81%
2020โ‚น101.52 B7.44%
2019โ‚น94.49 B17.22%
2018โ‚น80.61 B86.16%
2017โ‚น43.30 B-23.52%
2016โ‚น56.62 B26.97%
2015โ‚น44.59 B22.3%
2014โ‚น36.46 B-46.07%
2013โ‚น67.61 B-21.85%
2012โ‚น86.51 B-20.59%
2011โ‚น108.95 B-8.91%
2010โ‚น119.61 B19.21%
2009โ‚น100.34 B